CEO: Daniel J. Abdun-Nabi

Advent Contact: Shahzad Malik

Developing and marketing innovative vaccines and therapeutics

Emergent Biosolutions is a global specialty biopharmaceutical company developing and marketing innovative vaccines and therapeutics for certain infectious diseases, oncology and autoimmunity

Advent invested in Microscience in 2001. Microscience was acquired by Emergent in 2005. Emergent listed on NYSE in November 2006 (NYSE:EBS).

Back